Leviten; Michael W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Leviten; Michael W..The latest application filed is for "huntingtin interacting protein gene disruptions, compositions and methods related thereto".

Company Profile

0.2.25

Leviten; Michael W. - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Huntingtin Interacting Protein Gene Disruptions, Compositions And Methods Related Thereto App 20070022487 - Leviten; Michael W.	2007-01-25
HSPC150-like gene disruptions, compositions and methods related thereto Grant 7,164,055 - Leviten January 16, 2	2007-01-16
Transgenic mice containing deubiquitinated enzyme gene disruptions App 20060179504 - Leviten; Michael W.	2006-08-10
ADAM-like protease disruptions, compositions and methods related thereto App 20060162004 - Leviten; Michael W.	2006-07-20
Transgenic mice containing tryptase gene disruptions App 20060143721 - Allen; Keith D. ; et al.	2006-06-29
Transgenic mice containing chordin gene disruptions App 20060143720 - Leviten; Michael W.	2006-06-29
Transgenic mice containing beta3GalT2 gene disruptions App 20060101534 - Leviten; Michael W.	2006-05-11
Transgenic mice containing TMEM3 beta-1,3-N-acetylglucosaminyltransferase gene disruptions App 20060101533 - Leviten; Michael W.	2006-05-11
Transgenic mice exhibiting increased susceptibility to seizures Grant 6,653,526 - Leviten November 25, 2	2003-11-25
UBE2G2 ubiquitin-conjugating enzyme gene disruptions, compositions and methods related thereto App 20030177514 - Leviten, Michael W.	2003-09-18
HSPC150-like gene disruptions, compositions and methods related thereto App 20030046721 - Leviten, Michael W.	2003-03-06
USP3-like deubiquitinating enzyme gene disruptions, compositions and methods related thereto App 20030046720 - Leviten, Michael W.	2003-03-06
Transgenic mice containing USP3-like deubiquitinating enzyme gene disruptions App 20030014771 - Leviten, Michael W.	2003-01-16
Transgenic mice containing ubiquitin enzyme gene disruptions App 20030009779 - Leviten, Michael W.	2003-01-09
Transgenic mice containing beta3GalT2 gene disruptions App 20030005477 - Leviten, Michael W.	2003-01-02
ADAM-like protease disruptions, compositions and methods related thereto App 20030005474 - Leviten, Michael W.	2003-01-02
Transgenic mice containing ubiquitin protein ligase E3 gene disruptions App 20020194627 - Leviten, Michael W.	2002-12-19
Transgenic mice containing cash gene disruptions App 20020174450 - Allen, Keith D. ; et al.	2002-11-21
Transgenic mice containing cerberus gene disruptions App 20020162131 - Leviten, Michael W. ; et al.	2002-10-31
Transgenic mice containing deubiquitinated enzyme gene disruptions App 20020133842 - Leviten, Michael W.	2002-09-19
Transgenic mice containing huntingtin interacting protein gene disruptions App 20020133841 - Leviten, Michael W.	2002-09-19
Transgenic mice containing chordin gene disruptions App 20020038468 - Leviten, Michael W.	2002-03-28
Transgenic mice containing ubiquitin-specific protease 16 gene disruptions App 20020032914 - Leviten, Michael W.	2002-03-14
Transgenic mice containing serine protease gene disruptions App 20020026653 - Allen, Keith D. ; et al.	2002-02-28
Transgenic mice containing tryptase gene disruptions App 20020026654 - Allen, Keith D. ; et al.	2002-02-28
Transgenic mice containing ubiquitin-specific protease gene disruptions App 20020022719 - Leviten, Michael W.	2002-02-21
Transgenic mice containing matrix metalloprotease gene disruptions App 20020023275 - Leviten, Michael W.	2002-02-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.